Literature DB >> 8095867

Response of grafts from patients with alopecia areata transplanted onto nude mice, to administration of interferon-gamma.

A Gilhar1, A Etzioni, B Assy, S Eidelman.   

Abstract

A variety of evidence has pointed to immunological involvement in the pathogenesis of alopecia areata (AA). The aim of the present study was to determine whether differential expression of HLA-DR and intracellular adhesion molecules-1 (ICAM-1) occurs in hair structures of patients with longstanding AA, following stimulation with interferon-gamma (IFN-gamma). IFN-gamma was injected i.v. to nude mice grafted with transplants obtained from affected areas of seven patients and of normal individuals. All mice were injected with IFN-gamma or phosphate-buffered saline (PBS) alone for 3 consecutive days. Immunohistochemical studies were performed in specimens of grafts in order to detect the change in adhesion molecules, HLA-DR antigen, and Langerhans cells. ICAM-1 and HLA-DR induction was found to be similar in grafts from AA patients and normal skin grafts in the IFN-gamma injected mice. However, more intraepithelial Langerhans cells were observed in the AA patients' grafts treated with IFN-gamma than in those treated with PBS and in normal grafts treated with IFN-gamma. This study suggests an important role of Langerhans cells in this issue.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8095867     DOI: 10.1006/clin.1993.1015

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  5 in total

Review 1.  Lymphocytes, neuropeptides, and genes involved in alopecia areata.

Authors:  Amos Gilhar; Ralf Paus; Richard S Kalish
Journal:  J Clin Invest       Date:  2007-08       Impact factor: 14.808

2.  Percutaneous absorption of biologically-active interferon-gamma in a human skin graft-nude mouse model.

Authors:  S M Short; B D Paasch; J H Turner; N Weiner; A L Daugherty; R J Mrsny
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

Review 3.  What causes alopecia areata?

Authors:  K J McElwee; A Gilhar; D J Tobin; Y Ramot; J P Sundberg; M Nakamura; M Bertolini; S Inui; Y Tokura; L E King; B Duque-Estrada; A Tosti; A Keren; S Itami; Y Shoenfeld; A Zlotogorski; R Paus
Journal:  Exp Dermatol       Date:  2013-09       Impact factor: 3.960

4.  SOCS3 treatment prevents the development of alopecia areata by inhibiting CD8+ T cell-mediated autoimmune destruction.

Authors:  Zhen Gao; Yu-Qing Jin; Wei Wu
Journal:  Oncotarget       Date:  2017-05-16

5.  Induction of alopecia areata in C3H/HeJ mice using polyinosinic-polycytidylic acid (poly[I:C]) and interferon-gamma.

Authors:  Jung-Min Shin; Dae-Kyoung Choi; Kyung-Cheol Sohn; Jung-Woo Koh; Young Ho Lee; Young-Joon Seo; Chang Deok Kim; Jeung-Hoon Lee; Young Lee
Journal:  Sci Rep       Date:  2018-08-21       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.